ClickHouse vs Insilico Medicine

ClickHouse — Infrastructure · Private · $1.1B raised · 2 of 2 figures sourced  |  Insilico Medicine — Application · Public · $4.3B mkt cap · 5 of 5 figures sourced

Relationship

Assembled from the recorded fields for this pair, not hand-checked. The comparison below is read from each company’s own profile.

Aligned comparison

FieldClickHouseInsilico Medicine
Size$1.1B raised$4.3B mkt cap different basis
Employees—333
Founded20212014 7 yrs earlier
StatusPrivatePublic
CategoryInfrastructureApplication
Stack layerAgent platform, Data service, PlatformApplication, Hardware, Platform
HeadquartersSan Francisco Bay Area, USAHong Kong

Capability overlap

Shared · 3

Agent orchestrationData analysisEvaluation and observability

Not verified for Insilico Medicine · 2

Code generationVector search

Recorded for ClickHouse. Insilico Medicine’s product records say nothing either way — a missing record is not a missing capability.

Not verified for ClickHouse · 5

Drug discoveryModel trainingKnowledge retrievalSummarizationText generation

Recorded for Insilico Medicine. ClickHouse’s product records say nothing either way — a missing record is not a missing capability.

Products, side by side

Algorithmic pairing — assembled from recorded fields, not hand-checked

ClickHouse

Platform

ClickStackPlatform

Agent-native observability platform ('observability built for agents and humans') combining semantic investigation tools -- trace waterfalls, event-pattern detection, time-series analysis -- with ClickHouse's analytical engine, distinct from the existing ClickHouse Agents no-code builder.

Insilico Medicine

Platform

Biology42: Generative BiologicsPlatform

AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.

Chemistry42Platform

Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.

MMAI GymPlatform

Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.

PandaOmicsPlatform

AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.

Pharma.AIPlatform

End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.

No counterpart

ClickHouse sells these in a stack layer with no product recorded for Insilico Medicine yet — nothing on the other side to compare them against.

Agent platform

ClickHouse AgentsAgent platform

A no-code, conversational agent builder inside ClickHouse Cloud that lets users query and analyze ClickHouse data through natural-language chat, with Claude models wired in as the default.

Data service

ClickHouse CloudData service

Managed ClickHouse service on AWS, GCP and Azure whose console carries ClickHouse's own AI layer — the ClickHouse Assistant for writing and debugging SQL, the no-code ClickHouse Agents builder, a remote MCP server and Langfuse Cloud for LLM observability — on top of the open-source column-oriented analytics database.

Insilico Medicine sells these in a stack layer with no product recorded for ClickHouse yet — nothing on the other side to compare them against.

Application

Science42: DORAApplication

AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.

inClinicoApplication

Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.

Hardware

PandaOmics BoxHardware

On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.